Prediction of Survival After Partial Hepatectomy Using a Physiologically Based Pharmacokinetic Model of Indocyanine Green Liver Function Tests

The evaluation of hepatic function and functional capacity of the liver are essential tasks in hepatology as well as in hepatobiliary surgery. Indocyanine green (ICG) is a widely applied test compound that is used in clinical routine to evaluate hepatic function. Important questions for the function...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Adrian Köller, Jan Grzegorzewski, Hans-Michael Tautenhahn, Matthias König
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/99e58f9672544bdca25df699213c3b28
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:99e58f9672544bdca25df699213c3b28
record_format dspace
spelling oai:doaj.org-article:99e58f9672544bdca25df699213c3b282021-11-22T07:19:27ZPrediction of Survival After Partial Hepatectomy Using a Physiologically Based Pharmacokinetic Model of Indocyanine Green Liver Function Tests1664-042X10.3389/fphys.2021.730418https://doaj.org/article/99e58f9672544bdca25df699213c3b282021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphys.2021.730418/fullhttps://doaj.org/toc/1664-042XThe evaluation of hepatic function and functional capacity of the liver are essential tasks in hepatology as well as in hepatobiliary surgery. Indocyanine green (ICG) is a widely applied test compound that is used in clinical routine to evaluate hepatic function. Important questions for the functional evaluation with ICG in the context of hepatectomy are how liver disease such as cirrhosis alters ICG elimination, and if postoperative survival can be predicted from preoperative ICG measurements. Within this work a physiologically based pharmacokinetic (PBPK) model of ICG was developed and applied to the prediction of the effects of a liver resection under various degrees of cirrhosis. For the parametrization of the computational model and validation of model predictions a database of ICG pharmacokinetic data was established. The model was applied (i) to study the effect of liver cirrhosis and liver resection on ICG pharmacokinetics; and (ii) to evaluate the model-based prediction of postoperative ICG-R15 (retention ratio 15 min after administration) as a measure for postoperative outcome. Key results are the accurate prediction of changes in ICG pharmacokinetics caused by liver cirrhosis and postoperative changes of ICG-elimination after liver resection, as validated with a wide range of data sets. Based on the PBPK model, individual survival after liver resection could be classified, demonstrating its potential value as a clinical tool.Adrian KöllerJan GrzegorzewskiHans-Michael TautenhahnMatthias KönigFrontiers Media S.A.articleindocyanine greenhepatectomyliver cirrhosismathematical modelcomputational modelpharmacokineticsPhysiologyQP1-981ENFrontiers in Physiology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic indocyanine green
hepatectomy
liver cirrhosis
mathematical model
computational model
pharmacokinetics
Physiology
QP1-981
spellingShingle indocyanine green
hepatectomy
liver cirrhosis
mathematical model
computational model
pharmacokinetics
Physiology
QP1-981
Adrian Köller
Jan Grzegorzewski
Hans-Michael Tautenhahn
Matthias König
Prediction of Survival After Partial Hepatectomy Using a Physiologically Based Pharmacokinetic Model of Indocyanine Green Liver Function Tests
description The evaluation of hepatic function and functional capacity of the liver are essential tasks in hepatology as well as in hepatobiliary surgery. Indocyanine green (ICG) is a widely applied test compound that is used in clinical routine to evaluate hepatic function. Important questions for the functional evaluation with ICG in the context of hepatectomy are how liver disease such as cirrhosis alters ICG elimination, and if postoperative survival can be predicted from preoperative ICG measurements. Within this work a physiologically based pharmacokinetic (PBPK) model of ICG was developed and applied to the prediction of the effects of a liver resection under various degrees of cirrhosis. For the parametrization of the computational model and validation of model predictions a database of ICG pharmacokinetic data was established. The model was applied (i) to study the effect of liver cirrhosis and liver resection on ICG pharmacokinetics; and (ii) to evaluate the model-based prediction of postoperative ICG-R15 (retention ratio 15 min after administration) as a measure for postoperative outcome. Key results are the accurate prediction of changes in ICG pharmacokinetics caused by liver cirrhosis and postoperative changes of ICG-elimination after liver resection, as validated with a wide range of data sets. Based on the PBPK model, individual survival after liver resection could be classified, demonstrating its potential value as a clinical tool.
format article
author Adrian Köller
Jan Grzegorzewski
Hans-Michael Tautenhahn
Matthias König
author_facet Adrian Köller
Jan Grzegorzewski
Hans-Michael Tautenhahn
Matthias König
author_sort Adrian Köller
title Prediction of Survival After Partial Hepatectomy Using a Physiologically Based Pharmacokinetic Model of Indocyanine Green Liver Function Tests
title_short Prediction of Survival After Partial Hepatectomy Using a Physiologically Based Pharmacokinetic Model of Indocyanine Green Liver Function Tests
title_full Prediction of Survival After Partial Hepatectomy Using a Physiologically Based Pharmacokinetic Model of Indocyanine Green Liver Function Tests
title_fullStr Prediction of Survival After Partial Hepatectomy Using a Physiologically Based Pharmacokinetic Model of Indocyanine Green Liver Function Tests
title_full_unstemmed Prediction of Survival After Partial Hepatectomy Using a Physiologically Based Pharmacokinetic Model of Indocyanine Green Liver Function Tests
title_sort prediction of survival after partial hepatectomy using a physiologically based pharmacokinetic model of indocyanine green liver function tests
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/99e58f9672544bdca25df699213c3b28
work_keys_str_mv AT adriankoller predictionofsurvivalafterpartialhepatectomyusingaphysiologicallybasedpharmacokineticmodelofindocyaninegreenliverfunctiontests
AT jangrzegorzewski predictionofsurvivalafterpartialhepatectomyusingaphysiologicallybasedpharmacokineticmodelofindocyaninegreenliverfunctiontests
AT hansmichaeltautenhahn predictionofsurvivalafterpartialhepatectomyusingaphysiologicallybasedpharmacokineticmodelofindocyaninegreenliverfunctiontests
AT matthiaskonig predictionofsurvivalafterpartialhepatectomyusingaphysiologicallybasedpharmacokineticmodelofindocyaninegreenliverfunctiontests
_version_ 1718417870811037696